InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Dalgleish Scott, Chief Financial Officer. Officer active across 1 companies, notably Oncology Institute, Inc.. In total, 3 reports have been published. The latest transaction was disclosed on 21 March 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations3 total
032,092 shares0
Common stock
SEC:0001628280-22-007103:0·
047,566 shares0
Common Stock
SEC:0001104659-21-140226·
047,566 shares0
Common Stock
SEC:0001104659-21-140226:0·
3 of 3 declarations
About Dalgleish Scott
Scott Dalgleish serves as the Chief Financial Officer of Oncology Institute, Inc. In this role, he is responsible for managing the company's finances, including budgeting and financial analysis.
